Joseph M. Smith
Senior VP & Chief Scientific OfficerDr. Joseph M. Smith, also known as Joe, M.D., Ph.D., F.A.C.C, serves as Member of Advisory Board of Phlow Corp. since February 2023. He serves as Executive Chairman of The Learning Corp. Dr. Smith has been the Chief Executive Officer of Reflexion Health, Inc. since March 2016 and serves as its President. Dr. Smith serves as Senior Vice President and Chief Scientific officer at Becton, Dickinson and Company since November 29, 2021 and served as its Co-Chair of Scientific Advisory Board since November 2021. Dr. Smith joins BD from Digital Health Corp, a holding company where he served as president and CEO, responsible for the company's strategy to invest in or acquire digital health and therapeutic technologies. He has also served as academic faculty at Washington University School of Medicine and Department of Biomedical Engineering. Dr. Smith served as Co-Manager at The West Health Investment Fund. Dr. Smith served as the Chief Medical Officer and Chief Science Officer at The Gary and Mary West Health Institute, where he was leading initiatives to identify and accelerate the use of wireless health technologies and better target solutions to unmet medical needs and seeks to advance West Health’s mission to pioneer new and smarter technologies, policies and practices to make high-quality healthcare more accessible at a lower cost, with a focus on making successful aging a reality for all seniors. Dr. Smith served as the inaugural Chief Medical and Science Officer at the West Wireless Health Institute. He served as President of the West Health Policy Center in Washington, D.C. He served as the Chief Medical Officer and Chief Science Officer at West Health. His role encompasses directing the West Health Institute’s medical and clinical research. Dr. Smith is an Advisor to various academic and medical organizations including Johns Hopkins Biomedical Engineering, the Harvard-MIT Division of Health Science and Technology, the Wellcome Trust, Boston University, Case Western University, University of Miami, Children’s Hospital and The Johns Hopkins University. He served as the Vice President of Emerging Technologies at Johnson & Johnson in the Corporate Office of Science and Technology. Prior to that, he served as a Senior Vice President and Chief Medical Officer at Guidant, Boston Scientific and Cardiac Rhythm Management. He has served in executive leadership roles in Guidant, Boston Scientific and Johnson & Johnson with responsibilities including business development, venture investment, public policy and clinical studies. Dr. Smith also founded the Arrhythmia Institute. He spent nearly two decades in the clinical and academic practice of cardiology and cardiac electrophysiology, holding positions at the School of Medicine and the Department of Biomedical Engineering at Washington University, starting at the Brigham and Women's hospital, with sub-specialty training in clinical cardiac electrophysiology. He was also an Advisor to many leading universities and foundations as well as a broad range of venture backed medical technology startups including a number of innovative healthcare and technology start-up companies. He served as the Chairman of The Gary and Mary West Health Policy Center, Inc. He served as a Director of Svelte Medical Systems, Inc. Dr. Smith has been a Director of Reflexion Health, Inc. since October 2012. He serves as Board Observer of GlySens Incorporated. He serves as a Board Member of The Gary and Mary West Health Policy Center, Inc. He serves as Member of Advisory Board at Vasoptic Medical Inc. He was also a Member of the Board of Directors at The West Health Investment Fund. Dr. Smith is a Fellow of the American College of Cardiology, the American Heart Association and the American Institute for Medical and Biological Engineering. Dr. Smith was named one of 20 People Who Make Healthcare Better by HealthLeaders Magazine in 2010. He is a Harvard-trained physician with comprehensive clinical experience in medicine, cardiology and clinical cardiac electrophysiology. He has testified before Congress on the value of healthcare technology and the potential of wireless health technology to lower healthcare costs. He's also a member of the Food and Drug Administration Safety Innovation Act (FDASIA) workgroup. Dr. Smith has an extensive career at the intersection of clinical medicine and engineering. He has strategic, engineering and clinical expertise to make high-quality healthcare more accessible at a lower cost. He is a member of the board of directors at four, private companies including Constant Therapy Health, Inc; EP Sciences, Inc.; PDS, Inc.; and Ocudyne, Inc. Dr. Smith holds a Ph.D. in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology, an M.D. from Harvard Medical School and an M.S. in Electrical Engineering from the Massachusetts Institute of Technology. Dr. Smith holds a bachelor's degree in electrical and biomedical engineering from The Johns Hopkins University.
Positions
- Company NameBecton, Dickinson and CompanyStock CodeBDXPositionSenior VP & Chief Scientific OfficerColleagues
- TEThomas E. PolenPresident, CEO & Chairman
- MCMichael C. FeldExecutive VP & Chief Revenue Officer
- VRVitor RoqueExecutive VP & CFO
- EMElizabeth McCombsExecutive VP & CTO
- CIChristopher Ian Montague JonesIndependent Director
- CMCatherine M. BurzikIndependent Director
- RARobert Andrew EckertLead Independent Director
- JWJeffrey W. HendersonIndependent Director
